The resource provides information on TB basics for individuals receiving TB treatment. Topics covered include the differences between latent TB infection and TB disease, treatment, and resources.
The guide details messaging and strategies to help advocates and activists ensure that the LAM test is made available in-country.
The infographic explains how the CDC's TB laboratory supports health departments, shares the laboratory's mission, details laboratory partnerships, and more.
The video contains information on the basics of TB infection, targeted testing, recommendations for screening and testing high-risk groups, and patient education messages.
This video presents information on the difference between TB infection and disease, testing methods and recommendations, and interpretation of test results. The video also discusses special considerations for testing and the medical...
This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information...
This material was developed for clinicians to use with patients that are prescribed the four months daily rifampin (4R) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake...
This resource is a pocket-sized manual for clinicians and providers managing patients with TB disease and latent TB infection. ...
This material summarizes the U.S. recommendations for latent TB infection testing and treatment. The document includes information on who should be tested for TB infection, recommended treatment regimens for latent TB infection, and more.
The resource is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources.
